Skip to main navigation

Home
Overview
News & Publications
News Releases Publications
Events & Presentations
Governance
Documents & Charters Leadership and Board Committee Composition
Stock
Stock Quote & Chart Analyst Coverage
Financials
SEC Filings
IR Resources
Email Alerts Contact Us

Events and Presentations

Corporate Presentation

May 9, 2023

Corporate Presentation 3.8 MB

Past Events

Apr 19, 2023

HCW9218 Underlying Mechanism of Action Against Solid Tumors, AACR Annual Meeting 2023

Poster Presentation 1.1 MB

Nov 14, 2022

A Phase 1 Study of HCW9218, a Bifunctional TGF-β Antagonist/IL-15 Protein Complex, in Advanced Solid Tumors, SITC Annual Meeting 2022

Poster Presentation 848.8 KB

May 9, 2022

Robust human regulatory T cell expansion with fusion proteins HCW9302 and HCW9213 circumvents need for magnetic-bead or feeder cell approaches for adoptive cell therapy – Immunology 2022

Robust human regulatory T cell expansion with fusion proteins HCW9302 and HCW9213 circumvents need for magnetic-bead or feeder cell approaches for adoptive cell therapy – Immunology 2022 942.9 KB

May 9, 2022

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022 1.1 MB

Jan 19, 2022

Video: Dr. Hing C. Wong’s Presentation at the 21st Annual PepTalk 2022

Jan 11, 2022

Extending Health Span with Focus on Chronic Inflammation Induced by Chemotherapy Used to Treat Age-Related Diseases with Dr. Hing Wong HCW Biologics on Empowered Patient Podcast with Karen Jagoda

Listen to podcast

Transcript 211.5 KB

Jan 6, 2022

The Bio Report with Daniel Levine - Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging – Hing C. Wong, Ph.D.

Listen to podcast

Oct 13, 2021

HCW Biologics and the treatment of Inflammaging, Interview with Dr. Peter Rhode on Health Professional Radio

Sep 9, 2021

Meet HCW Biologics: Fly exclusive interview with CEO Hing Wong HCWB - The Fly

May 1, 2020

A Novel IL2-based Immunotherapeutic Protein Prevents the Development of Atherosclerosis in ApoE−/− mice and LDLR−/− mice

Qiongzhen li, Xiaoyun Zhu, Catherine Spanoudis, Kristine Ravelo, Mike Dee, Bai Liu, Caitlin Prendes, Lijing You and Hing Wong
J Immunol May 1, 2020, 204 (1 Supplement) 159.19

© HCW Biologics, Inc. 2021 - 2023